- /
- Supported exchanges
- / US
- / DRUG.NASDAQ
Bright Minds Biosciences Inc (DRUG NASDAQ) stock market data APIs
Bright Minds Biosciences Inc Financial Data Overview
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Bright Minds Biosciences Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Bright Minds Biosciences Inc data using free add-ons & libraries
Get Bright Minds Biosciences Inc Fundamental Data
Bright Minds Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: -2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Bright Minds Biosciences Inc Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-08-14
- EPS/Forecast: -1.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bright Minds Biosciences Inc News
New
Sector Update: Healthcare Stocks Ease Late Afternoon
Healthcare stocks eased late Monday afternoon with the NYSE Healthcare Index down 0.1% and the State Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news ...
Top 3 Canadian Biotech Stocks To Watch In October 2026
US GDP growth running at a 3.4% annual pace puts risk assets back in focus, and that includes Canadian biotech stocks that can react sharply when money flows into higher risk ideas. Stronger US activi...
3 Canadian Biotech Stocks With Up To 39% Net Margins
Oil prices recently moved above $110 a barrel as conflict risks around Iran and Saudi Arabia increased, and that puts global inflation and healthcare costs back in the spotlight. For Canadian biotech ...
3 Canadian Biotech Stocks Trading Up To 93% Below Fair Value
Global investors are questioning high priced AI and tech stories after a sharp sell off in AI linked shares, which has pushed attention back toward areas like Canadian biotech where progress depends m...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.